EQS-Adhoc: MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year

 

 

 

EQS-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in ForecastMeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year 21-Aug-2025 / 17:45 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.The issuer is solely responsible for the content of this announcement.

Bremen, August 21, 2025 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its forecast for the current fiscal year based on preliminary figures for the first ten months.

For fiscal year 2024/2025 (October 1, 2024 to September 30, 2025), revenue is now expected to decline slightly to between €16.5 million and €17.0 million (previous forecast: €17.0 million to €17.5 million). MeVis expects EBIT (earnings before interest and taxes) to decline to between €3.0 million and €3.5 million (previous forecast: €3.5 million to €4.0 million).

License sales are below expectations and cannot be offset by maintenance revenues and other revenues.

************************************************************************

Contact:Kirchhoff, Marcus / CEO
End of Inside Information

21-Aug-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir@mevis.de
Internet: www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2187294
 
End of Announcement EQS News Service

2187294  21-Aug-2025 CET/CEST

 

 

Back